Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat
| dc.contributor.author | Waheed, Anam A | |
| dc.contributor.author | Ghanchi, Najia K | |
| dc.contributor.author | Rehman, Karim A | |
| dc.contributor.author | Raza, Afsheen | |
| dc.contributor.author | ETAL.. | |
| dc.date.accessioned | 2023-03-10T05:44:55Z | |
| dc.date.accessioned | 2023-08-19T08:47:31Z | |
| dc.date.available | 2023-03-10T05:44:55Z | |
| dc.date.available | 2023-08-19T08:47:31Z | |
| dc.date.issued | 2015-12 | |
| dc.description.abstract | In Pakistan, Plasmodium vivax contributes to major malaria burden. In this case, a pregnant woman presented with P. vivax infection and which was not cleared by chloroquine, despite adequate treatment. This is probably the first confirmed case of chloroquine-resistant vivax from Pakistan, where severe malaria due to P. vivax is already an emerging problem. | en_US |
| dc.identifier.citation | Waheed, A. A., Ghanchi, N. K., Rehman, K. A., Raza, A., Mahmood, S. F., & Beg, M. A. (2015). Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat. Malaria Journal, 14, 1-3. | en_US |
| dc.identifier.doi | https://doi.org/10.1186/s12936-015-0660-0 | |
| dc.identifier.uri | https://edms.wexl.in/handle/1/4349 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer Link | en_US |
| dc.subject | Malaria | en_US |
| dc.subject | Chloroquine resistance | en_US |
| dc.subject | Artemisinin combination therapy | en_US |
| dc.title | Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat | en_US |
| dc.title.alternative | Journal article | en_US |
| dc.type | Article | en_US |